Using a different experimental setting, a combination of anti-IFN-α and anti-IFN-β neutralizing antibodies was added at the beginning of ZIKV infection to block the effect of endogenous virus-induced IFN. The gene discussed is IFNA1; the disease is Zika virus infectious disease.